Yahoo Web Search

Search results

1. • Small Business - Cordele Dispatch | Cordele Dispatch

     Cordele Dispatch· 1 day ago

     Dr. Markku Jalkanen and Dr. Sirpa Jalkanen, Faron’s co-founders, have been nominated as one of three finalists in the ‘SMEs’ category of prestigious European Patent Office AwardsNominated in recognition of research developing bexmarilimab, an

2. • Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald

     Roanoke-Chowan News-Herald· 2 days ago

     Preliminary safety and efficacy with sustained objective responses observed in patients with lymphoma treated with MT-601 in Phase 1 APOLLO study Study participant with Non-Hodgkin’s Lymphoma who relapsed within 90 days of anti-CD19 CAR T cell

3. • 

     Earnings call: Moleculin Biotech optimistic on Annamycin's future By Investing.com

     Investing.com· 4 days ago

     The company has secured a composition of matter patent for Annamycin, ensuring market exclusivity...

4. • Curis Announces Additional Data from TakeAim Leukemia Study

     WRBL Columbus· 3 days ago

     Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced updated data from ...

5. • Moleculin Reports First Quarter 2024 Financial Results and Provides Corporate Update

     FOX 23 News Albany· 4 days ago

     Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses ...

6. • Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald

     Roanoke-Chowan News-Herald· 3 days ago

     – Observed encouraging complete response (CR) rates as of the February 1, 2024, data cutoff in previously untreated HR-MDS and TP53m AML patients; successfully bridged responding TP53m AML patients to hematopoietic cell transplantation – – SL

7. • Affimed (NASDAQ:AFMD) Short Interest Update

     ETF DAILY NEWS· 15 hours ago

     Affimed (NASDAQ:AFMD – Get Free Report) was the target of a significant decrease in short interest in the month of April. As of April 30th, there was short interest totalling 204,100 shares, ...

8. • 

     Earnings call: Moleculin Biotech optimistic on Annamycin's future By Investing.com

     Investing.com· 4 days ago

     The company has secured a composition of matter patent for Annamycin, ensuring market exclusivity...

9. • Syros Pharmaceuticals (NASDAQ:SYRS) Upgraded by StockNews.com to Hold

     ETF DAILY NEWS· 1 day ago

     StockNews.com upgraded shares of Syros Pharmaceuticals (NASDAQ:SYRS – Free Report) from a sell rating to a hold rating in a research report sent to investors on Wednesday morning. Several other ...

10. • Celularity Inc. (NASDAQ:CELUW) Short Interest Up 34.4% in April

      ETF DAILY NEWS· 3 days ago

      Celularity Inc. (NASDAQ:CELUW – Get Free Report) was the recipient of a significant increase in short interest in the month of April. As of April 30th, there was short interest totalling 161,700 ...